Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells

Jie Han, Wen Hou, Leslie A. Goldstein, Caisheng Lu, Donna B. Stolz, Xiao-Ming Yin, Hannah Rabinowich

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

Targeting TRAIL receptors with either recombinant TRAIL or agonistic DR4- or DR5-specific antibodies has been considered a promising treatment for cancer, particularly due to the preferential apoptotic susceptibility of tumor cells over normal cells to TRAIL. However, the realization that many tumors are unresponsive to TRAIL treatment has stimulated interest in identifying apoptotic agents that when used in combination with TRAIL can sensitize tumor cells to TRAIL-mediated apoptosis. Our studies suggest that various apoptosis defects that block TRAIL-mediated cell death at different points along the apoptotic signaling pathway shift the signaling cascade from default apoptosis toward cytoprotective autophagy. We also obtained evidence that inhibition of such a TRAIL-mediated autophagic response by specific knockdown of autophagic genes initiates an effective mitochondrial apoptotic response that is caspase-8-dependent. Currently, the molecular mechanisms linking disabled autophagy to mitochondrial apoptosis are not known. Our analysis of the molecular mechanisms involved in the shift from protective autophagy to apoptosis in response to TRAIL sheds new light on the negative regulation of apoptosis by the autophagic process and by some of its individual components.

Original languageEnglish (US)
Pages (from-to)19665-19677
Number of pages13
JournalJournal of Biological Chemistry
Volume283
Issue number28
DOIs
StatePublished - Jul 11 2008
Externally publishedYes

Fingerprint

Autophagy
Tumors
Cells
Apoptosis
Neoplasms
TNF-Related Apoptosis-Inducing Ligand Receptors
Gene Knockdown Techniques
Caspase 8
Cell death
Cell Death
Genes
Defects
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. / Han, Jie; Hou, Wen; Goldstein, Leslie A.; Lu, Caisheng; Stolz, Donna B.; Yin, Xiao-Ming; Rabinowich, Hannah.

In: Journal of Biological Chemistry, Vol. 283, No. 28, 11.07.2008, p. 19665-19677.

Research output: Contribution to journalArticle

Han, Jie ; Hou, Wen ; Goldstein, Leslie A. ; Lu, Caisheng ; Stolz, Donna B. ; Yin, Xiao-Ming ; Rabinowich, Hannah. / Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. In: Journal of Biological Chemistry. 2008 ; Vol. 283, No. 28. pp. 19665-19677.
@article{d640efe0511b464fa9e30af5048713dc,
title = "Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells",
abstract = "Targeting TRAIL receptors with either recombinant TRAIL or agonistic DR4- or DR5-specific antibodies has been considered a promising treatment for cancer, particularly due to the preferential apoptotic susceptibility of tumor cells over normal cells to TRAIL. However, the realization that many tumors are unresponsive to TRAIL treatment has stimulated interest in identifying apoptotic agents that when used in combination with TRAIL can sensitize tumor cells to TRAIL-mediated apoptosis. Our studies suggest that various apoptosis defects that block TRAIL-mediated cell death at different points along the apoptotic signaling pathway shift the signaling cascade from default apoptosis toward cytoprotective autophagy. We also obtained evidence that inhibition of such a TRAIL-mediated autophagic response by specific knockdown of autophagic genes initiates an effective mitochondrial apoptotic response that is caspase-8-dependent. Currently, the molecular mechanisms linking disabled autophagy to mitochondrial apoptosis are not known. Our analysis of the molecular mechanisms involved in the shift from protective autophagy to apoptosis in response to TRAIL sheds new light on the negative regulation of apoptosis by the autophagic process and by some of its individual components.",
author = "Jie Han and Wen Hou and Goldstein, {Leslie A.} and Caisheng Lu and Stolz, {Donna B.} and Xiao-Ming Yin and Hannah Rabinowich",
year = "2008",
month = "7",
day = "11",
doi = "10.1074/jbc.M710169200",
language = "English (US)",
volume = "283",
pages = "19665--19677",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells

AU - Han, Jie

AU - Hou, Wen

AU - Goldstein, Leslie A.

AU - Lu, Caisheng

AU - Stolz, Donna B.

AU - Yin, Xiao-Ming

AU - Rabinowich, Hannah

PY - 2008/7/11

Y1 - 2008/7/11

N2 - Targeting TRAIL receptors with either recombinant TRAIL or agonistic DR4- or DR5-specific antibodies has been considered a promising treatment for cancer, particularly due to the preferential apoptotic susceptibility of tumor cells over normal cells to TRAIL. However, the realization that many tumors are unresponsive to TRAIL treatment has stimulated interest in identifying apoptotic agents that when used in combination with TRAIL can sensitize tumor cells to TRAIL-mediated apoptosis. Our studies suggest that various apoptosis defects that block TRAIL-mediated cell death at different points along the apoptotic signaling pathway shift the signaling cascade from default apoptosis toward cytoprotective autophagy. We also obtained evidence that inhibition of such a TRAIL-mediated autophagic response by specific knockdown of autophagic genes initiates an effective mitochondrial apoptotic response that is caspase-8-dependent. Currently, the molecular mechanisms linking disabled autophagy to mitochondrial apoptosis are not known. Our analysis of the molecular mechanisms involved in the shift from protective autophagy to apoptosis in response to TRAIL sheds new light on the negative regulation of apoptosis by the autophagic process and by some of its individual components.

AB - Targeting TRAIL receptors with either recombinant TRAIL or agonistic DR4- or DR5-specific antibodies has been considered a promising treatment for cancer, particularly due to the preferential apoptotic susceptibility of tumor cells over normal cells to TRAIL. However, the realization that many tumors are unresponsive to TRAIL treatment has stimulated interest in identifying apoptotic agents that when used in combination with TRAIL can sensitize tumor cells to TRAIL-mediated apoptosis. Our studies suggest that various apoptosis defects that block TRAIL-mediated cell death at different points along the apoptotic signaling pathway shift the signaling cascade from default apoptosis toward cytoprotective autophagy. We also obtained evidence that inhibition of such a TRAIL-mediated autophagic response by specific knockdown of autophagic genes initiates an effective mitochondrial apoptotic response that is caspase-8-dependent. Currently, the molecular mechanisms linking disabled autophagy to mitochondrial apoptosis are not known. Our analysis of the molecular mechanisms involved in the shift from protective autophagy to apoptosis in response to TRAIL sheds new light on the negative regulation of apoptosis by the autophagic process and by some of its individual components.

UR - http://www.scopus.com/inward/record.url?scp=50349098812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50349098812&partnerID=8YFLogxK

U2 - 10.1074/jbc.M710169200

DO - 10.1074/jbc.M710169200

M3 - Article

VL - 283

SP - 19665

EP - 19677

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -